PneumaScan installed in Hospital Kuala Lumpur
20 February 2012
Cambridge company PneumaCare Limited has installed its
innovative PneumaScan respiratory assessment device in Hospital Kuala
Lumpur (HKL), the largest hospital under the Ministry of Health in
Dr Ward Hills, PneumaCare’s CEO, and Dr Simon Baker the Product
Director, delivered the device to Datuk Dr Jeyaindran Sinnadurai,
Head of the Department of General Medicine at HKL, where it will be
used to benefit a diverse range of patients.
"We were impressed with the ease with which the PneumaScan was
installed and how straightforward it is to use after a comprehensive
two-day training course," comments Dr Jeyaindran. "Nearly 10% of our
admissions — that is 11,000 patients a year — are solely related to
respiratory disease. Many of those could be helped by this device.
"We also intend to use it to further our research into patient
care. Two of my general practitioners, Dr Paras Doshi and Dr Zulfa
Siti, have been assigned to collect data using PneumaScan on
patients within the Cardiac Rehabilitation Ward (CRW). The aim of
our studies is to research whether the PneumaCare instrument can
infer clinically relevant information before conducting invasive
On the final day of the PneumaScan training programme, the Chief
Secretary to the Government of Malaysia, Tan Sri Mohd Sidek bin Haji
Hassan, was visiting HKL. He was introduced to the PneumaCare team
and actively took part in a demonstration of the device.
"Operating in Malaysia gives us the opportunity to explore the
instrument’s performance on a wide range of ethnicities and in
different environments," says Ward Hills. "For example, we hope to
learn how comparable are results of lung capacities between ethnic
groups to standard expected results. We are anticipating significant
new data in the areas of cardio-thoracic, respiratory medicine and
general pulmonary function testing.
"Specifically we are aiming for clinical collaborations and
datasets looking at diseases such as COPD and tuberculosis, the
latter being almost impossible to obtain in Western Europe. This
will enable us to continue to improve and develop the effectiveness
and applicability of our software and hardware."
The company says that discussions are taking place with other
healthcare institutions in Malaysia, including the Malaysia
Institute of Respiratory Medicine in Kuala Lumpur, on patient care
and research collaborations, as well as multi-centre trials and
research projects and international placements with PneumaCare users
in the UK.